$2.46 -0.03 (-1.21%) Rigel Pharmaceuticals Inc - NASDAQ

May. 27, 2016 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 2.46
Trade Time: May 27 04:00 PM Eastern Daylight Time
Change: -0.03 (-1.21%)
Prev Close: 2.49
Open: 2.48
Bid: 2.46
Ask: 2.47

Competitors

Ticker Name Volume % Change
AZN AstraZeneca Shs Sponsored American Deposit Share Repr 1/2 Sh 4.90M -0.23%
BMY Bristol-Myers Squibb Co 3.63M +0.82%
TST.TO Telesta Therapeutics 870.20K -6.25%
IRWD Ironwood Pharmaceuticals Inc 788.65K +1.23%
INVA Innoviva Inc 467.60K -1.76%

RIGL Stock Analysis

  1. No results found.

Partner Headlines

  1. Rigel Completes Enrollment of First Phase 3 Study of Fostamatinib in ITP

    Benzinga | Jan. 28, 2016 | 07:37AM EST
  2. Rigel Granted Orphan Drug Designation for Fostamatinib in ITP

    Benzinga | Sep. 8, 2015 | 07:30AM EST
  3. Earnings Scheduled For March 3, 2015

    Benzinga | Mar. 3, 2015 | 04:18AM EST
  4. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  5. Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) ...

    GuruFocus | Feb. 23, 2015 | 14:58PM EST
  6. Morning Market Gainers

    Benzinga | Feb. 23, 2015 | 09:44AM EST